Filter
176
Text search:
counterfeit
drug
Featured
Recommendations
10
New Publications
56
Language
Document type
No document type
100
Studies & Reports
34
Guidelines
22
Manuals
7
Strategic & Response Plan
7
Situation Updates
3
Training Material
2
Fact sheets
1
Countries / Regions
Kenya
11
Uganda
10
Nigeria
7
Ethiopia
7
Ghana
7
Tanzania
6
Liberia
5
Cambodia
5
Sierra Leone
4
Zambia
4
Malawi
4
Botswana
4
Myanmar / Burma
4
Zimbabwe
3
South Africa
3
Bangladesh
3
Eswatini/ Swaziland
3
Cameroon
2
Philippines
2
Rwanda
2
Namibia
2
Ukraine
2
South–East Asia Region
2
Global
2
Burkina Faso
1
Congo, Democratic Republic of
1
Haiti
1
India
1
Somalia
1
Nepal
1
Pakistan
1
Thailand
1
China
1
Indonesia
1
Mozambique
1
Lesotho
1
Asia
1
Africa
1
Laos
1
Moldova
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
95
Public Health
8
Clinical Guidelines
8
Pharmacy & Technologies
6
Key Resources
2
Women & Child Health
1
Toolboxes
Pharmacy
30
AMR
28
Mental Health
6
TB
5
HIV
4
Global Health Education
4
Conflict
2
Rapid Response
2
Planetary Health
2
Disability
1
Specific Hazards
1
COVID-19
1
Caregiver
1
NCDs
1
Third edition.
The main changes within the third edition of the JEE tool include the split of the technical area National legislation, policy, and financing into two technical areas (Legal instruments and Financing); the drop of the technical area previously titled Reporting and the move of indicat
...
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli ...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli ...
The report explores strategies for sustaining the country’s responses to the three diseases and eventually transitioning away from external funding and programmatic support. It takes stock of Kenya’s health financing landscape and identifies opportunities and challenges for sustaining effective
...
Poor quality health services are holding back progress on improving health in countries at all income levels.
Today, inaccurate diagnosis, medication errors, inappropriate or unnecessary treatment, inadequate or unsafe clinical facilities or practices, or providers who lack adequate training an ...
Today, inaccurate diagnosis, medication errors, inappropriate or unnecessary treatment, inadequate or unsafe clinical facilities or practices, or providers who lack adequate training an ...
The National Health Plan (NHP) aims to strengthen the country’s health system and pave the way towards Universal Health Coverage (UHC),choosing a path that is explicitly pro-poor. The main goal of NHP 2017-2021 is to extend access to a Basic Essential Package of Health Services (EPHS) to the entir
...
The key aim of this guideline is to present recommendations based on a critical evaluation of the evidence on emerging digital health interventions that are contributing to health system improvements, based on an assessment of the benefits, harms, acceptability, feasibility, resource use and equity
...
Joint Action for Results
UNAIDS Outcome Framework: Business Case 2009–2011
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect
...
The International Pharmaceutical Federation (FIP) is a global federation of national associations of pharmacists and
pharmaceutical scientists. In order to support these associations in their fight against AMR, FIP has prepared this
briefing document. It is an overview of the different activities
...
A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production
WHO would like to express its gratitude and appreciation to all Member States that provided information to the WHO survey on policies and activities at the national level in the area of antimicrobial resistance. The contribution of staff in WHO Regional and Country Offices has been invaluable: in ga
...
South Africa has faced many challenges over the past two decades, accomplishing profound positive changes in the social structure and government of the nation. This has not yet fully translated into better health for the population, however, particularly the poorest segment. In fact, the p
...
ຢາຕ້ານເຊື້ອຈຸລະຊີບ (Antimicrobial medicines) ມີຄວາມສໍາຄັນຫຼາຍຕໍ່ວຽກງານການແພດ, ສາທາລະນະສຸກ, ສຸຂະພາບສັດ ແລະ ການຜະລິດອາຫານ. ເນ
...
This policy brief has been developed in response to the contemporary challenge of antibiotic resistance (ABR). ABR poses a formidable threat to global health and sustainable development. It is now increasingly recognized that the systematic neglect of cultural factors is one of the biggest obs
...
